
Global Travelers Vaccines Industry Growth and Trends Forecast to 2031
Description
Summary
According to APO Research, The global Travelers Vaccines market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for Travelers Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for Travelers Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for Travelers Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global manufacturers of Travelers Vaccines include Biokangtai, CNBG, Sanofi Pasteur, Sanofi Pasteur MSD, Serum Institute of India, GlaxoSmithKline, Pfizer and Merck, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Travelers Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Travelers Vaccines.
The Travelers Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Travelers Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Travelers Vaccines Segment by Company
Biokangtai
CNBG
Sanofi Pasteur
Sanofi Pasteur MSD
Serum Institute of India
GlaxoSmithKline
Pfizer
Merck
Travelers Vaccines Segment by Type
Hepatitis Vaccine
Japanese Encephalitis Vaccine
Meningococcal Vaccine
Cholera Vaccine
Yellow Fever Vaccine
Other
Travelers Vaccines Segment by Application
Tourists
Students
Workers
Others
Travelers Vaccines Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Travelers Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Travelers Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Travelers Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Travelers Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Travelers Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, The global Travelers Vaccines market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for Travelers Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for Travelers Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for Travelers Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global manufacturers of Travelers Vaccines include Biokangtai, CNBG, Sanofi Pasteur, Sanofi Pasteur MSD, Serum Institute of India, GlaxoSmithKline, Pfizer and Merck, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Travelers Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Travelers Vaccines.
The Travelers Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Travelers Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Travelers Vaccines Segment by Company
Biokangtai
CNBG
Sanofi Pasteur
Sanofi Pasteur MSD
Serum Institute of India
GlaxoSmithKline
Pfizer
Merck
Travelers Vaccines Segment by Type
Hepatitis Vaccine
Japanese Encephalitis Vaccine
Meningococcal Vaccine
Cholera Vaccine
Yellow Fever Vaccine
Other
Travelers Vaccines Segment by Application
Tourists
Students
Workers
Others
Travelers Vaccines Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Travelers Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Travelers Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Travelers Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Travelers Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Travelers Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
90 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Travelers Vaccines Market Size Estimates and Forecasts (2020-2031)
- 1.2.2 Global Travelers Vaccines Sales Estimates and Forecasts (2020-2031)
- 1.3 Travelers Vaccines Market by Type
- 1.3.1 Hepatitis Vaccine
- 1.3.2 Japanese Encephalitis Vaccine
- 1.3.3 Meningococcal Vaccine
- 1.3.4 Cholera Vaccine
- 1.3.5 Yellow Fever Vaccine
- 1.3.6 Other
- 1.4 Global Travelers Vaccines Market Size by Type
- 1.4.1 Global Travelers Vaccines Market Size Overview by Type (2020-2031)
- 1.4.2 Global Travelers Vaccines Historic Market Size Review by Type (2020-2025)
- 1.4.3 Global Travelers Vaccines Forecasted Market Size by Type (2026-2031)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Travelers Vaccines Sales Breakdown by Type (2020-2025)
- 1.5.2 Europe Travelers Vaccines Sales Breakdown by Type (2020-2025)
- 1.5.3 Asia-Pacific Travelers Vaccines Sales Breakdown by Type (2020-2025)
- 1.5.4 South America Travelers Vaccines Sales Breakdown by Type (2020-2025)
- 1.5.5 Middle East and Africa Travelers Vaccines Sales Breakdown by Type (2020-2025)
- 2 Global Market Dynamics
- 2.1 Travelers Vaccines Industry Trends
- 2.2 Travelers Vaccines Industry Drivers
- 2.3 Travelers Vaccines Industry Opportunities and Challenges
- 2.4 Travelers Vaccines Industry Restraints
- 3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Travelers Vaccines Revenue (2020-2025)
- 3.2 Global Top Players by Travelers Vaccines Sales (2020-2025)
- 3.3 Global Top Players by Travelers Vaccines Price (2020-2025)
- 3.4 Global Travelers Vaccines Industry Company Ranking, 2023 VS 2024 VS 2025
- 3.5 Global Travelers Vaccines Major Company Production Sites & Headquarters
- 3.6 Global Travelers Vaccines Company, Product Type & Application
- 3.7 Global Travelers Vaccines Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Travelers Vaccines Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Travelers Vaccines Players Market Share by Revenue in 2024
- 3.8.3 2023 Travelers Vaccines Tier 1, Tier 2, and Tier 3
- 4 Travelers Vaccines Regional Status and Outlook
- 4.1 Global Travelers Vaccines Market Size and CAGR by Region: 2020 VS 2024 VS 2031
- 4.2 Global Travelers Vaccines Historic Market Size by Region
- 4.2.1 Global Travelers Vaccines Sales in Volume by Region (2020-2025)
- 4.2.2 Global Travelers Vaccines Sales in Value by Region (2020-2025)
- 4.2.3 Global Travelers Vaccines Sales (Volume & Value), Price and Gross Margin (2020-2025)
- 4.3 Global Travelers Vaccines Forecasted Market Size by Region
- 4.3.1 Global Travelers Vaccines Sales in Volume by Region (2026-2031)
- 4.3.2 Global Travelers Vaccines Sales in Value by Region (2026-2031)
- 4.3.3 Global Travelers Vaccines Sales (Volume & Value), Price and Gross Margin (2026-2031)
- 5 Travelers Vaccines by Application
- 5.1 Travelers Vaccines Market by Application
- 5.1.1 Tourists
- 5.1.2 Students
- 5.1.3 Workers
- 5.1.4 Others
- 5.2 Global Travelers Vaccines Market Size by Application
- 5.2.1 Global Travelers Vaccines Market Size Overview by Application (2020-2031)
- 5.2.2 Global Travelers Vaccines Historic Market Size Review by Application (2020-2025)
- 5.2.3 Global Travelers Vaccines Forecasted Market Size by Application (2026-2031)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Travelers Vaccines Sales Breakdown by Application (2020-2025)
- 5.3.2 Europe Travelers Vaccines Sales Breakdown by Application (2020-2025)
- 5.3.3 Asia-Pacific Travelers Vaccines Sales Breakdown by Application (2020-2025)
- 5.3.4 South America Travelers Vaccines Sales Breakdown by Application (2020-2025)
- 5.3.5 Middle East and Africa Travelers Vaccines Sales Breakdown by Application (2020-2025)
- 6 Company Profiles
- 6.1 Biokangtai
- 6.1.1 Biokangtai Comapny Information
- 6.1.2 Biokangtai Business Overview
- 6.1.3 Biokangtai Travelers Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 6.1.4 Biokangtai Travelers Vaccines Product Portfolio
- 6.1.5 Biokangtai Recent Developments
- 6.2 CNBG
- 6.2.1 CNBG Comapny Information
- 6.2.2 CNBG Business Overview
- 6.2.3 CNBG Travelers Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 6.2.4 CNBG Travelers Vaccines Product Portfolio
- 6.2.5 CNBG Recent Developments
- 6.3 Sanofi Pasteur
- 6.3.1 Sanofi Pasteur Comapny Information
- 6.3.2 Sanofi Pasteur Business Overview
- 6.3.3 Sanofi Pasteur Travelers Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 6.3.4 Sanofi Pasteur Travelers Vaccines Product Portfolio
- 6.3.5 Sanofi Pasteur Recent Developments
- 6.4 Sanofi Pasteur MSD
- 6.4.1 Sanofi Pasteur MSD Comapny Information
- 6.4.2 Sanofi Pasteur MSD Business Overview
- 6.4.3 Sanofi Pasteur MSD Travelers Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 6.4.4 Sanofi Pasteur MSD Travelers Vaccines Product Portfolio
- 6.4.5 Sanofi Pasteur MSD Recent Developments
- 6.5 Serum Institute of India
- 6.5.1 Serum Institute of India Comapny Information
- 6.5.2 Serum Institute of India Business Overview
- 6.5.3 Serum Institute of India Travelers Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 6.5.4 Serum Institute of India Travelers Vaccines Product Portfolio
- 6.5.5 Serum Institute of India Recent Developments
- 6.6 GlaxoSmithKline
- 6.6.1 GlaxoSmithKline Comapny Information
- 6.6.2 GlaxoSmithKline Business Overview
- 6.6.3 GlaxoSmithKline Travelers Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 6.6.4 GlaxoSmithKline Travelers Vaccines Product Portfolio
- 6.6.5 GlaxoSmithKline Recent Developments
- 6.7 Pfizer
- 6.7.1 Pfizer Comapny Information
- 6.7.2 Pfizer Business Overview
- 6.7.3 Pfizer Travelers Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 6.7.4 Pfizer Travelers Vaccines Product Portfolio
- 6.7.5 Pfizer Recent Developments
- 6.8 Merck
- 6.8.1 Merck Comapny Information
- 6.8.2 Merck Business Overview
- 6.8.3 Merck Travelers Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 6.8.4 Merck Travelers Vaccines Product Portfolio
- 6.8.5 Merck Recent Developments
- 7 North America by Country
- 7.1 North America Travelers Vaccines Sales by Country
- 7.1.1 North America Travelers Vaccines Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 7.1.2 North America Travelers Vaccines Sales by Country (2020-2025)
- 7.1.3 North America Travelers Vaccines Sales Forecast by Country (2026-2031)
- 7.2 North America Travelers Vaccines Market Size by Country
- 7.2.1 North America Travelers Vaccines Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 7.2.2 North America Travelers Vaccines Market Size by Country (2020-2025)
- 7.2.3 North America Travelers Vaccines Market Size Forecast by Country (2026-2031)
- 8 Europe by Country
- 8.1 Europe Travelers Vaccines Sales by Country
- 8.1.1 Europe Travelers Vaccines Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 8.1.2 Europe Travelers Vaccines Sales by Country (2020-2025)
- 8.1.3 Europe Travelers Vaccines Sales Forecast by Country (2026-2031)
- 8.2 Europe Travelers Vaccines Market Size by Country
- 8.2.1 Europe Travelers Vaccines Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 8.2.2 Europe Travelers Vaccines Market Size by Country (2020-2025)
- 8.2.3 Europe Travelers Vaccines Market Size Forecast by Country (2026-2031)
- 9 Asia-Pacific by Country
- 9.1 Asia-Pacific Travelers Vaccines Sales by Country
- 9.1.1 Asia-Pacific Travelers Vaccines Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 9.1.2 Asia-Pacific Travelers Vaccines Sales by Country (2020-2025)
- 9.1.3 Asia-Pacific Travelers Vaccines Sales Forecast by Country (2026-2031)
- 9.2 Asia-Pacific Travelers Vaccines Market Size by Country
- 9.2.1 Asia-Pacific Travelers Vaccines Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 9.2.2 Asia-Pacific Travelers Vaccines Market Size by Country (2020-2025)
- 9.2.3 Asia-Pacific Travelers Vaccines Market Size Forecast by Country (2026-2031)
- 10 South America by Country
- 10.1 South America Travelers Vaccines Sales by Country
- 10.1.1 South America Travelers Vaccines Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 10.1.2 South America Travelers Vaccines Sales by Country (2020-2025)
- 10.1.3 South America Travelers Vaccines Sales Forecast by Country (2026-2031)
- 10.2 South America Travelers Vaccines Market Size by Country
- 10.2.1 South America Travelers Vaccines Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 10.2.2 South America Travelers Vaccines Market Size by Country (2020-2025)
- 10.2.3 South America Travelers Vaccines Market Size Forecast by Country (2026-2031)
- 11 Middle East and Africa by Country
- 11.1 Middle East and Africa Travelers Vaccines Sales by Country
- 11.1.1 Middle East and Africa Travelers Vaccines Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 11.1.2 Middle East and Africa Travelers Vaccines Sales by Country (2020-2025)
- 11.1.3 Middle East and Africa Travelers Vaccines Sales Forecast by Country (2026-2031)
- 11.2 Middle East and Africa Travelers Vaccines Market Size by Country
- 11.2.1 Middle East and Africa Travelers Vaccines Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 11.2.2 Middle East and Africa Travelers Vaccines Market Size by Country (2020-2025)
- 11.2.3 Middle East and Africa Travelers Vaccines Market Size Forecast by Country (2026-2031)
- 12 Value Chain and Sales Channels Analysis
- 12.1 Travelers Vaccines Value Chain Analysis
- 12.1.1 Travelers Vaccines Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Travelers Vaccines Production Mode & Process
- 12.2 Travelers Vaccines Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Travelers Vaccines Distributors
- 12.2.3 Travelers Vaccines Customers
- 13 Concluding Insights
- 14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.